“Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis” (2024) Swiss Medical Weekly, 154(7), p. 3695. doi:10.57187/s.3695.